184 related articles for article (PubMed ID: 36354990)
1. Oncolytic Vaccinia Virus Carrying
Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
[No Abstract] [Full Text] [Related]
2. Oncolytic Vaccinia Virus Harboring
Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
[TBL] [Abstract][Full Text] [Related]
3. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic Vaccinia Virus Expressing
Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic Vaccinia Virus Harboring
Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
[No Abstract] [Full Text] [Related]
7.
Li G; Cheng J; Mei S; Wu T; Ye T
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
Wang X; Zhou N; Liu T; Jia X; Ye T; Chen K; Li G
Mar Drugs; 2021 May; 19(6):. PubMed ID: 34064193
[TBL] [Abstract][Full Text] [Related]
9.
Li G; Mei S; Cheng J; Wu T; Luo J
Mar Drugs; 2018 Apr; 16(5):. PubMed ID: 29701680
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma.
Deng L; Yang X; Ding Y; Fan J; Peng Y; Xu D; Huang B; Hu Z
Virol J; 2022 Mar; 19(1):44. PubMed ID: 35292065
[TBL] [Abstract][Full Text] [Related]
11. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently.
Ady JW; Heffner J; Mojica K; Johnsen C; Belin LJ; Love D; Chen CT; Pugalenthi A; Klein E; Chen NG; Yu YA; Szalay AA; Fong Y
Surgery; 2014 Aug; 156(2):263-9. PubMed ID: 24957667
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
14. Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma.
Meng G; Li B; Chen A; Zheng M; Xu T; Zhang H; Dong J; Wu J; Yu D; Wei J
Br J Cancer; 2020 Jan; 122(1):111-120. PubMed ID: 31819179
[TBL] [Abstract][Full Text] [Related]
15. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic measles virus enhances antitumour responses of adoptive CD8
Chen A; Zhang Y; Meng G; Jiang D; Zhang H; Zheng M; Xia M; Jiang A; Wu J; Beltinger C; Wei J
Sci Rep; 2017 Jul; 7(1):5170. PubMed ID: 28701757
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma.
Ady JW; Johnsen C; Mojica K; Heffner J; Love D; Pugalenthi A; Belin LJ; Chen NG; Yu YA; Szalay AA; Fong Y
Surgery; 2015 Aug; 158(2):331-8. PubMed ID: 26049609
[TBL] [Abstract][Full Text] [Related]
18. An oncolytic adenovirus delivering TSLC1 inhibits Wnt signaling pathway and tumor growth in SMMC-7721 xenograft mice model.
Wang Y; Huang P; Hu Y; Guo K; Jia X; Huang B; Liu X; He X; Huang F
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):766-774. PubMed ID: 33928346
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.
Penghui Y; Fang S; Ruilan W; Guanglin L; Hongjing G; Yueqiang D; Zhongpeng Z; Xiaolan Y; Zhaohai W; Shaogeng Z; Xiliang W
Hum Gene Ther; 2019 Mar; 30(3):330-338. PubMed ID: 30205709
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.
Breitbach CJ; Arulanandam R; De Silva N; Thorne SH; Patt R; Daneshmand M; Moon A; Ilkow C; Burke J; Hwang TH; Heo J; Cho M; Chen H; Angarita FA; Addison C; McCart JA; Bell JC; Kirn DH
Cancer Res; 2013 Feb; 73(4):1265-75. PubMed ID: 23393196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]